G56R (p.Gly56Arg) variant of ATXN1 (Ataxin-1)

G56R (p.Gly56Arg) in ATXN1 (Ataxin-1) is a missense change. Clinical records from UniProt describe it as variant assessed as somatic; moderate impact. The available variant effect predictions contribute to a CATVariant prioritization score of 0.33 / 1. The record also includes population frequency data and structural context.

G56R (p.Gly56Arg) variant details